Clinical evaluation of pharmacist interventions in patients treated with anti-methicillin-resistant Staphylococcus aureus agents in a hematological ward

Biological and Pharmaceutical Bulletin

Volumn 39, Issue 2, 2016, Pages 295-300

  Okada, Naoto ^a,b   Fushitani, Shuji ^a   Azuma, Momoyo ^a   Nakamura, Shingen ^a,b   Nakamura, Toshimi ^a   Teraoka, Kazuhiko ^a   Watanabe, Hiroyoshi ^a,b   Abe, Masahiro ^b   Kawazoe, Kazuyoshi ^b   Ishizawa, Keisuke ^a,b  

^a TOKUSHIMA UNIVERSITY HOSPITAL   (Japan)

^b UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Arbekacin; Pharmacist intervention; Teicoplanin; Therapeutic drug monitoring; Vancomycin

Indexed keywords

HABEKACIN; TEICOPLANIN; VANCOMYCIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL OUTCOME; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG INDICATION; DRUG MONITORING; FEBRILE NEUTROPENIA; FEMALE; HEMATOLOGIC MALIGNANCY; HOSPITALIZATION; HUMAN; LEUKEMIA; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PHARMACEUTICAL CARE; PHARMACIST; UNIVERSITY HOSPITAL; WARD; DRUG EFFECTS; DRUG UTILIZATION; HOSPITAL; MICROBIOLOGY; MIDDLE AGED; PROCEDURES; RETROSPECTIVE STUDY; STANDARDS; STAPHYLOCOCCAL INFECTIONS; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; DRUG MONITORING; DRUG UTILIZATION; FEMALE; HOSPITALS; HUMANS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; PHARMACISTS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 85011854087     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/BPB.B15-00774     Document Type: Article

References (16)

1. Begg EJ, Atkinson HC, Jeffery GM, Taylor NW. Individualised aminoglycoside dosage based on pharmacokinetic analysis is superior to dosage based on physician intuition at achieving target plasma drug concentrations. Br. J. Clin. Pharmacol., 28, 137-141 (1989).
2. Imaura M, Kohata Y, Kobayashi K, Takahashi H, Yokoyama H, Akase T, Yamada Y. Effect of pharmacists' intervention on the antibiotic therapy for the methicillin-resistant Staphylococcus aureus (MRSA) infectious diseases in the intensive care unit. Yakugaku Zasshi, 131, 563-570 (2011).
3. Arizumi H, Maeda T, Nakashima H, Hattori N, Yanagisawa K, Saito B, Harada H, Nakamaki T, Mori H, Tomoyasu S. A descriptive epidemiological study of hematological disorders in Showa University Hospital. J. Showa Univ. Society, 73, 224-231 (2013).
4. Terui Y. Strategies of treatment for febrile neutropenia. Gan To Kagaku Ryoho, 40, 688-692 (2013).
5. Sugimoto M, Yonezawa A, Tadehara M, Morita Y, Yoshida Y, Onoue M, Omura T, Kayano Y, Fukatsu S, Yano I, Matsubara K. Protocol-based pharmacotherapy management (PBPM) involving ward-pharmacists as a member of medical team on outpatient prescriptions brought to the hospital. Jpn. J. Pharm. Health Care Sci., 40, 297-303 (2014).
6. Isetts BJ, Schondelmeyer SW, Heaton AH, Wadd WB, Hardie NA, Artz MB. Effects of collaborative drug therapy management on patients' perceptions of care and health-related quality of life. Res. Social Adm. Pharm., 2, 129-142 (2006).
7. Kajizono M, Aoyagi M, Kitmura Y, Sendo T. Effectiveness of medical supportive team for outpatients treated with sorafenib: a retrospective study. J. Pharm. Health Care Sci., 1, 39-44 (2015).
8. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron, 16, 31-41 (1976).
9. Masaoka T. Evidence-based recommendations for antimicrobial use in febrile neutropenia in Japan: Executive summary. Clin. Infect. Dis., 39 (Suppl. 1), S49-S52 (2004).
10. Matsumoto K, Shigemi A, Yaji K, Shimodozono Y, Takeda Y, Ikawa K, Morikawa N, Miyanohara H, Orita M, Tokuda K, Nishi J, Yamada K. Reduction in the incidence of MRSA with use of alcohol-based hand rub solutions and gloves. J. Infect. Chemother., 18, 269-271 (2012).
11. Matsumoto K, Takesue Y, Ohmagari N, Mochizuki T, Mikamo H, Seki M, Takakura S, Tokimatsu I, Takahashi Y, Kasahara K, Okada K, Igarashi M, Kobayashi M, Hamada Y, Kimura M, Nishi Y, Tanigawara Y, Kimura T. Practice guidelines for therapeutic drug monitoring of vancomycin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug Monitoring. J. Infect. Chemother., 19, 365-380 (2013).
12. Ueda T, Takesue Y, Nakajima K, Ichki K, Wada Y, Tsuchida T, Takahashi Y, Ishihara M, Tatsumi S, Kimura T, Ikeuchi H, Uchino M. Evaluation of teicoplanin dosing designs to achieve a new target trough concentration. J. Infect. Chemother., 18, 296-302 (2012).
13. Okada K, Kimura T, Mikamo H, Kasahara K, Seki M, Takakura S, Tokimatsu I, Ohmagari N, Takahashi Y, Matsumoto K, Igarashi M, Kobayashi M, Hamada Y, Mochizuki T, Kimura M, Nishi Y, Tanigawara Y, Takesue Y, Japanese Society of Chemotherapy, Japanese Society of Therapeutic Drug Monitoring. Clinical practice guidelines for therapeutic drug monitoring of arbekacin: A consensus review of the Japanese Society of Chemotherapy and the Japanese Society of Therapeutic Drug monitoring. J. Infect. Chemother., 20, 1-5 (2014).
14. Hoste EA, Clermont G, Kersten A, Venkataraman R, Angus DC, De Bacquer D, Kellum JA. RIFLE criteria for acute kidney injury are associated with hospital mortality in critically ill patients: A cohort analysis. Crit. Care, 10, R73 (2006).
15. Welty TE, Copa AK. Impact of vancomycin therapeutic drug monitoring on patient care. Ann. Pharmacother., 28, 1335-1339 (1994).
16. Freifeld AG, Bow EJ, Sepkowitz KA, Boeckh MJ, Ito JI, Mullen CA, Raad II, Rolston KV, Young JA, Wingard JR, Infectious Diseases Society of America. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 Update by the Infectious Diseases Society of America. Clin. Infect. Dis., 52, 427-431 (2011).